LeMaitre Vascular, Inc. (LMAT)

Market Cap	2.43B
Revenue (ttm)	213.03M
Net Income (ttm)	41.32M
Shares Out	22.48M
EPS (ttm)	1.82
PE Ratio	59.29
Forward PE	51.56
Dividend	$0.64 (0.59%)
Ex-Dividend Date	Nov 21, 2024

Volume	128,578
Open	106.64
Previous Close	105.87
Day's Range	106.10 - 108.09
52-Week Range	51.70 - 108.09
Beta	0.88
Analysts	Buy
Price Target	92.83 (-14.02%)
Earnings Date	Oct 31, 2024

About LMAT

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Oct 19, 2006
• Employees: 630
• Stock Exchange: NASDAQ
• Ticker Symbol: LMAT
• Website: https://www.lemaitre.com

Financial Performance

In 2023, LeMaitre Vascular's revenue was $193.48 million, an increase of 19.69% compared to the previous year's $161.65 million. Earnings were $30.11 million, an increase of 45.89%.

Analyst Forecast

According to 7 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $92.83, which is a decrease of -14.02% from the latest price.

Price Target

$92.83

(-14.02% downside)

Analyst Consensus: Buy